BD Medical

BD Medical
Share

BD Medical

 •  February 10, 2016

Tests from DiabetOmics to be Integrated into BD Veritor™ Point-of-Care Diagnostic Platform Tests from DiabetOmics to be Integrated into BD Veritor™ Point-of-Care Diagnostic Platform
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has entered into a licensing and distribution agreement for clinical tests from DiabetOmics Inc., a private global medical diagnostics company,...

BD Medical

 •  February 8, 2016

Innovation Results from Collaboration with the National Institutes of Health Innovation Results from Collaboration with the National Institutes of Health
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony™ system, a novel cell analyzer enabling the simultaneous measurement of up to 50 different characteristics of a single cell.
The BD...

BD Medical

 •  January 8, 2016

Becton, Dickinson and Company (BD) (NYSE: BDX) and Fresenius Kabi USA announced today that Fresenius Kabi has acquired the BD Rx business, which includes a pharmaceutical manufacturing plant in Wilson, N.C., and the BD Simplist™ line of seven drugs in ready-to-administer prefilled glass syringes.
Fresenius Kabi and BD have also signed a 10-year...

BD Medical

 •  January 8, 2016

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Fresenius Kabi USA has acquired the BD Rx business, which includes a pharmaceutical manufacturing plant in Wilson, N.C., and the BD Simplist™ line of seven drugs in ready-to-administer prefilled glass syringes.
BD and Fresenius Kabi...

BD Medical

 •  January 4, 2016

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 34th Annual J. P. Morgan Healthcare Conference on Wednesday, January 13, 2016, at 12:00 p.m. EST
A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors and will...

BD Medical

 •  December 7, 2015

Combined Technologies from BD, CareFusion Create End-to-End IV Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a simplified way for hospitals to manage intravenous (IV) medication to help improve safety and reduce waste.
National data show that 90 percent of hospital patients...

BD Medical

 •  December 2, 2015

Visit the “BD Leadership Theater” to hear how health systems improve and advance quality and safety across the continuum of care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and CareFusion, a BD company, will present its combined, strengthened solutions together as one company, at the 50th Annual...

BD Medical

 •  November 23, 2015

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.66 cents per common share, an increase of 10.0 percent from the previous quarter. The dividend will be payable on December 31, 2015 to holders of record on December 10, 2015. The indicated annual dividend rate for fiscal year 2016 is...

BD Medical

 •  October 1, 2015

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2015 earnings conference call on Wednesday, November 4, 2015, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter’s earnings earlier that morning.The webcast of the conference call, ...

BD Medical

 •  September 29, 2015

FDA Updates March 2015 Safety Alert on CSTD Compatibility for Treanda® Injection
(September 29, 2015) – Today BD (Becton, Dickinson and Company), notified customers that the U.S. Food and Drug Administration (FDA) has updated its March 2015 Safety Alert based on Teva Pharmaceuticals’ (Teva) findings which include that the BD PhaSeal™ System is the ...